1. Home
  2. KOPN vs DCTH Comparison

KOPN vs DCTH Comparison

Compare KOPN & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOPN
  • DCTH
  • Stock Information
  • Founded
  • KOPN 1984
  • DCTH 1988
  • Country
  • KOPN United States
  • DCTH United States
  • Employees
  • KOPN N/A
  • DCTH N/A
  • Industry
  • KOPN Semiconductors
  • DCTH Medical/Dental Instruments
  • Sector
  • KOPN Technology
  • DCTH Health Care
  • Exchange
  • KOPN Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • KOPN 424.9M
  • DCTH 388.3M
  • IPO Year
  • KOPN 1992
  • DCTH N/A
  • Fundamental
  • Price
  • KOPN $3.64
  • DCTH $11.97
  • Analyst Decision
  • KOPN Strong Buy
  • DCTH Strong Buy
  • Analyst Count
  • KOPN 4
  • DCTH 4
  • Target Price
  • KOPN $3.63
  • DCTH $24.50
  • AVG Volume (30 Days)
  • KOPN 7.0M
  • DCTH 727.2K
  • Earning Date
  • KOPN 11-11-2025
  • DCTH 11-07-2025
  • Dividend Yield
  • KOPN N/A
  • DCTH N/A
  • EPS Growth
  • KOPN N/A
  • DCTH N/A
  • EPS
  • KOPN N/A
  • DCTH 0.06
  • Revenue
  • KOPN $46,959,478.00
  • DCTH $70,240,000.00
  • Revenue This Year
  • KOPN $2.26
  • DCTH $159.22
  • Revenue Next Year
  • KOPN $30.33
  • DCTH $42.78
  • P/E Ratio
  • KOPN N/A
  • DCTH $213.94
  • Revenue Growth
  • KOPN 13.03
  • DCTH 491.35
  • 52 Week Low
  • KOPN $0.65
  • DCTH $8.87
  • 52 Week High
  • KOPN $4.11
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • KOPN 62.17
  • DCTH 60.51
  • Support Level
  • KOPN $2.98
  • DCTH $11.25
  • Resistance Level
  • KOPN $4.11
  • DCTH $12.70
  • Average True Range (ATR)
  • KOPN 0.36
  • DCTH 0.60
  • MACD
  • KOPN 0.05
  • DCTH 0.15
  • Stochastic Oscillator
  • KOPN 70.17
  • DCTH 70.44

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: